Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGEN International -- Ignore unavailable to you. Want to Upgrade?

To: John Zwiener who wrote (440)	9/18/1998 12:36:00 AM
From: James Perry	Read Replies (1) \| Respond to of 1025

And while I am unable to devine specifically - at this point - just what Sam announced today, concerning the proprietary means of testing inventories of potential drug molecules, for drug companies, I have a hunch it is a bit of a radical advance and will stir the high throughput market in a super sort of way. Sounds almost as if it has some means of finding its own way in making selections! What I am relatively confident about is that it should boom the big device sales. Any report as to progress in design and setting up a production line for those devices? That is the point at which I expect sales to turn a huge corner - you know, when you consider the fact that drug companies have come forward and contracted to buy these things when they havent even been designed, it really speaks to their potential. Of course, they did have evidence from the fact that Igen rigged a device together and used it to do a BIG bunch of testing for Aguron.